Oculis Holding AG (OCS)

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Biotechnology (Startups)	1.20M	686.00K	883.00K	912.00K	960.00K
Biotechnology (Startups) Growth	74.78%	-22.31%	-3.18%	-5.00%	-3.32%
Total	1.20M	686.00K	883.00K	912.00K	960.00K
Total Growth	74.78%	-22.31%	-3.18%	-5.00%	-3.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error